Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Shanghaiinstitute Of Materia Medica Chinese Academy Of Sciences currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct art unit, reflecting a specific technical focus for the company's current patent filings. Such concentration in 1 art unit allows the applicant to focus on a single set of examination standards and prior art.
The portfolio's prosecution is handled by 1 distinct examiner, HOWELL, THEODORE R. As the busiest examiner, HOWELL, THEODORE R is responsible for 1 pending office action. This means that the entirety of the company's current pending workload is under the review of this 1 examiner, which can facilitate a more consistent dialogue during the prosecution process.
For the legal team, the presence of 1 pending office action across 1 distinct examiner and 1 distinct art unit indicates a streamlined prosecution environment. In the Biotechnology & Pharmaceuticals sector, this level of centralization reduces the complexity of managing multiple examiner preferences. The strategy for this portfolio should be tailored specifically to the tendencies and requirements of HOWELL, THEODORE R.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOWELL, THEODORE R | 1 | 66.9% | +25.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694948 | LONG-CHAIN COMPOUND THAT ACTS ON ACLY, PREPARATION METHOD THEREFOR AND USE THEREOF | HOWELL, THEODORE R | — |
| Art Unit | Apps |
|---|---|
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18694948 | LONG-CHAIN COMPOUND THAT ACTS ON ACLY, PREPARATION METHOD THEREFOR AND USE THEREOF | HOWELL, THEODORE R | 1628 | §102§103DP | Non-Final OA | — | Pending | Mar 22, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialShanghaiinstitute Of Materia Medica Chinese Academy Of Sciences has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Theodore R Howell has the most, with 1 of Shanghaiinstitute Of Materia Medica Chinese Academy Of Sciences's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
